skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 75,197  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
S221 A Post-Hoc Safety Analysis of Oral Sulfate Tablet Preparation in Elderly Patients and Patients With Renal Insufficiency
S221 A Post-Hoc Safety Analysis of Oral Sulfate Tablet Preparation in Elderly Patients and Patients With Renal Insufficiency
Material Type:
Article 		Add to My Research

S221 A Post-Hoc Safety Analysis of Oral Sulfate Tablet Preparation in Elderly Patients and Patients With Renal Insufficiency

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S98-S98 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000773356.59119.c8

Full text available

Citations Cited by
2
S190 Docusate Is Not Different From Placebo for Stool Softening: A Comprehensive Review
S190 Docusate Is Not Different From Placebo for Stool Softening: A Comprehensive Review
Material Type:
Article 		Add to My Research

S190 Docusate Is Not Different From Placebo for Stool Softening: A Comprehensive Review

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S85-S85 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000773232.60122.be

Full text available

Citations Cited by
3
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies
Material Type:
Article 		Add to My Research

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]

Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970

Full text available

Citations Cited by
4
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Safety Of Indacaterol/glycopyrrolate 27.5/15.6 µg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Safety Of Indacaterol/glycopyrrolate 27.5/15.6 µg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies
Material Type:
Article 		Add to My Research

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Safety Of Indacaterol/glycopyrrolate 27.5/15.6 µg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]

Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970

Full text available

Citations Cited by
5
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis
Material Type:
Article 		Add to My Research

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]

Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970

Full text available

Citations Cited by
6
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies
Material Type:
Article 		Add to My Research

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Peer Reviewed Journal]

Copyright American Thoracic Society 2017 ;ISSN: 1073-449X ;EISSN: 1535-4970

Full text available

Citations Cited by
7
O24/205  WEB and CONTOUR: pros and cons of two intraaneurysmal flow disruptors after 4 years of parallel use. A single center experience
O24/205  WEB and CONTOUR: pros and cons of two intraaneurysmal flow disruptors after 4 years of parallel use. A single center experience
Material Type:
Conference Proceeding 		Add to My Research

O24/205  WEB and CONTOUR: pros and cons of two intraaneurysmal flow disruptors after 4 years of parallel use. A single center experience

Journal of neurointerventional surgery, 2023, Vol.15 (Suppl 2), p.A12-A13 [Peer Reviewed Journal]

2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1759-8478 ;EISSN: 1759-8486 ;DOI: 10.1136/jnis-2023-ESMINT.24

Full text available

Citations Cited by
8
S222 Oral Sulfate Tablets Are Safe in Cardiac and Hypertensive Patients Undergoing Colonoscopy—Results of a Post-Hoc Analysis
S222 Oral Sulfate Tablets Are Safe in Cardiac and Hypertensive Patients Undergoing Colonoscopy—Results of a Post-Hoc Analysis
Material Type:
Article 		Add to My Research

S222 Oral Sulfate Tablets Are Safe in Cardiac and Hypertensive Patients Undergoing Colonoscopy—Results of a Post-Hoc Analysis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S98-S98 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000773360.67972.4d

Full text available

Citations Cited by
9
S1039 Adverse Events Associated with the Use of FDA-Approved Innovative Duodenoscope Designs: An Analysis of Medical Device Reports (MDRs) from the Manufacturer and User Facility Device Experience (MAUDE) Database
S1039 Adverse Events Associated with the Use of FDA-Approved Innovative Duodenoscope Designs: An Analysis of Medical Device Reports (MDRs) from the Manufacturer and User Facility Device Experience (MAUDE) Database
Material Type:
Article 		Add to My Research

S1039 Adverse Events Associated with the Use of FDA-Approved Innovative Duodenoscope Designs: An Analysis of Medical Device Reports (MDRs) from the Manufacturer and User Facility Device Experience (MAUDE) Database

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S492-S492 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000777688.83037.90

Full text available

Citations Cited by
10
12 All lupus nephritis patients should be initially managed with both established standard therapies and the new generation drugs
12 All lupus nephritis patients should be initially managed with both established standard therapies and the new generation drugs
Material Type:
Article 		Add to My Research

12 All lupus nephritis patients should be initially managed with both established standard therapies and the new generation drugs

Lupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A6-A6 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.12

Full text available

Citations Cited by
11
O-017 Edinburgh’s WEB experience
O-017 Edinburgh’s WEB experience
Material Type:
Article 		Add to My Research

O-017 Edinburgh’s WEB experience

Journal of neurointerventional surgery, 2019-07, Vol.11 (Suppl 1), p.A12 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1759-8478 ;EISSN: 1759-8486 ;DOI: 10.1136/neurintsurg-2019-SNIS.17

Full text available

Citations Cited by
12
0473 Alendronate is Associated With a Significantly Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)
0473 Alendronate is Associated With a Significantly Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)
Material Type:
Article 		Add to My Research

0473 Alendronate is Associated With a Significantly Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)

Sleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A189-A190 [Peer Reviewed Journal]

Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. ;ISSN: 0161-8105 ;EISSN: 1550-9109 ;DOI: 10.1093/sleep/zsz067.471

Full text available

Citations Cited by
13
Ustekinumab Reinduction for Loss of Response or Interruption of Treatment: 667
Ustekinumab Reinduction for Loss of Response or Interruption of Treatment: 667
Material Type:
Article 		Add to My Research

Ustekinumab Reinduction for Loss of Response or Interruption of Treatment: 667

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S377-S378 [Peer Reviewed Journal]

Copyright Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins Oct 2018 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201810001-00667

Full text available

Citations Cited by
14
Mandated Payor Switching With Infliximab (IFX) Biosimilars: 2058
Mandated Payor Switching With Infliximab (IFX) Biosimilars: 2058
Material Type:
Article 		Add to My Research

Mandated Payor Switching With Infliximab (IFX) Biosimilars: 2058

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S1173-S1173 [Peer Reviewed Journal]

Copyright Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins Oct 2018 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/00000434-201810001-02058

Full text available

Citations Cited by
15
Rx Product News: January 2024
Rx Product News: January 2024
Material Type:
Article 		Add to My Research

Rx Product News: January 2024

Pharmacy times, 2024-01, Vol.90 (1)

Copyright MultiMedia Healthcare Inc. 2024 ;ISSN: 0003-0627 ;EISSN: 2168-7234

Full text available

Citations Cited by
16
Rx Product News - November 2023
Rx Product News - November 2023
Material Type:
Article 		Add to My Research

Rx Product News - November 2023

Pharmacy times, 2023-11, Vol.89 (11)

Copyright MultiMedia Healthcare Inc. 2023 ;ISSN: 0003-0627 ;EISSN: 2168-7234

Full text available

Citations Cited by
17
A Comprehensive Map of FDA-Approved Pharmaceutical Products
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Material Type:
Article 		Add to My Research

A Comprehensive Map of FDA-Approved Pharmaceutical Products

Pharmaceutics, 2018-12, Vol.10 (4), p.263 [Peer Reviewed Journal]

2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 by the authors. 2018 ;ISSN: 1999-4923 ;EISSN: 1999-4923 ;DOI: 10.3390/pharmaceutics10040263 ;PMID: 30563197

Full text available

Citations Cited by
18
0755 Pitolisant (Wakix) is an Effective Anti-Cataplexy Agent in Narcolepsy Type 1
0755 Pitolisant (Wakix) is an Effective Anti-Cataplexy Agent in Narcolepsy Type 1
Material Type:
Article 		Add to My Research

0755 Pitolisant (Wakix) is an Effective Anti-Cataplexy Agent in Narcolepsy Type 1

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A287-A287 [Peer Reviewed Journal]

Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. 2020 ;Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com. ;ISSN: 0161-8105 ;EISSN: 1550-9109 ;DOI: 10.1093/sleep/zsaa056.751

Full text available

Citations Cited by
19
S2517 Pill Prep Problems? Erosive Gastritis and Peptic Ulcers due to Sodium Sulfate-Based Tablet Bowel Prep
S2517 Pill Prep Problems? Erosive Gastritis and Peptic Ulcers due to Sodium Sulfate-Based Tablet Bowel Prep
Material Type:
Article 		Add to My Research

S2517 Pill Prep Problems? Erosive Gastritis and Peptic Ulcers due to Sodium Sulfate-Based Tablet Bowel Prep

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1676-e1676 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000866708.51952.b1

Full text available

Citations Cited by
20
Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide
Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide
Material Type:
Article 		Add to My Research

Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide

BMJ (Online), 2020-03, Vol.368, p.m1090-m1090 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1090 ;PMID: 32188598

Full text available

Citations Cited by

Results 1 - 20 of 75,197  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (33,173)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1972  (27)
  2. 1972 To 1984  (121)
  3. 1985 To 1997  (2,024)
  4. 1998 To 2011  (19,297)
  5. After 2011  (53,732)
  6. More options open sub menu

Subject 

  1. Fda Approval  (75,176)
  2. Science & Technology  (27,681)
  3. Life Sciences & Biomedicine  (25,415)
  4. Patients  (14,226)
  5. Clinical Trials  (13,349)
  6. Pharmaceutical Industry  (12,780)
  7. Humans  (12,440)
  8. Drug Dosages  (9,094)
  9. Cancer Therapies  (8,212)
  10. Drugs  (7,517)
  11. Prescription Drugs  (6,454)
  12. Oncology  (5,890)
  13. Tumors  (5,472)
  14. Cancer  (5,386)
  15. Proteins  (5,360)
  16. Medical Research  (5,033)
  17. Chemotherapy  (4,845)
  18. Review  (4,762)
  19. Pharmacology & Pharmacy  (4,706)
  20. Drug Therapy  (4,589)
  21. More options open sub menu

Language 

  1. English  (75,170)
  2. Japanese  (2,216)
  3. Portuguese  (42)
  4. Chinese  (29)
  5. German  (26)
  6. Turkish  (24)
  7. French  (17)
  8. Norwegian  (17)
  9. Spanish  (12)
  10. Italian  (10)
  11. Dutch  (6)
  12. Polish  (3)
  13. Korean  (3)
  14. Russian  (1)
  15. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait